Management of Hyperphosphataemia in Chronic Kidney Disease: Summary of National Institute for Health and Clinical Excellence (NICE) Guideline

Publisher： Karger

E-ISSN： 1660-2110|124|1-2|1-9

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.124, Iss.1-2, 2013-09, pp. : 1-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Has NICE got it right? An international perspective considering the case of Technology Appraisal No. 98 by the National Institute for Health and Clinical Excellence (NICE)

By Schlander Michael  

Current Medical Research and Opinion, Vol. 24, Iss. 4, 2008-04 ,pp. : 951-966

Informa Healthcare

Access to resources Recommend Favorite

A rational framework for decision making by the National Institute For Clinical Excellence (NICE)

By Claxton K.   Sculpher M.   Drummond M.  

The Lancet, Vol. 360, Iss. 334, 2002-08 ,pp. : 711-715

Elsevier

Access to resources Recommend Favorite

Public and Patient Involvement at the UK National Institute for Health and Clinical Excellence

By Barham Leela  

The Patient: Patient-Centered Outcomes Research, Vol. 4, Iss. 1, 2011-01 ,pp. : 1-10

Adis International

Access to resources Recommend Favorite

Renal Association Clinical Practice Guideline on Anaemia of Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 118, Iss. 1, 2011-05 ,pp. : c101-c124

Karger

Access to resources Recommend Favorite

A Critique of the UK NICE Guidance for the Detection and Management of Individuals with Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 113, Iss. 3, 2009-08 ,pp. : c207-c213

Karger

Access to resources Recommend Favorite